BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33959010)

  • 21. Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-κB pathways in the cartilage tissue of rats with osteoarthritis.
    Hu H; Yang B; Li Y; Zhang S; Li Z
    Int J Mol Med; 2016 Dec; 38(6):1922-1932. PubMed ID: 27748894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pioglitazone inhibits MMP-1 expression in vascular smooth muscle cells through a mitogen-activated protein kinase-independent mechanism.
    Game BA; Maldonado A; He L; Huang Y
    Atherosclerosis; 2005 Feb; 178(2):249-56. PubMed ID: 15694931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
    Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
    Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway.
    Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L
    Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IκBα degradation, and COX-2 expression in murine macrophages.
    Shao Q; Shen LH; Hu LH; Pu J; Jing Q; He B
    J Cell Biochem; 2012 Feb; 113(2):611-8. PubMed ID: 21956776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts.
    Park CH; Chung JH
    J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin attenuates plaque vulnerability by downregulation of EMMPRIN expression via COX-2/PGE2 pathway.
    Liang X; Yang LX; Guo R; Shi Y; Hou X; Yang Z; Zhou X; Liu H
    Exp Ther Med; 2017 Mar; 13(3):835-844. PubMed ID: 28450907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis.
    Yin Y; Liu W; Ji G; Dai Y
    Eur J Cell Biol; 2013; 92(4-5):150-9. PubMed ID: 23498167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages: inhibitory effect of fluvastatin.
    Abe N; Osanai T; Fujiwara T; Kameda K; Matsunaga T; Okumura K
    Life Sci; 2006 Jan; 78(9):1021-8. PubMed ID: 16182316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized LDL-Exposed Human Macrophages Display Increased MMP-9 Expression and Secretion Mediated by Endoplasmic Reticulum Stress.
    Sanda GM; Deleanu M; Toma L; Stancu CS; Simionescu M; Sima AV
    J Cell Biochem; 2017 Apr; 118(4):661-669. PubMed ID: 27341688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascochlorin suppresses oxLDL-induced MMP-9 expression by inhibiting the MEK/ERK signaling pathway in human THP-1 macrophages.
    Kang JH; Kim JK; Park WH; Park KK; Lee TS; Magae J; Nakajima H; Kim CH; Chang YC
    J Cell Biochem; 2007 Oct; 102(2):506-14. PubMed ID: 17407144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38.
    Lim M; Martinez T; Jablons D; Cameron R; Guo H; Toole B; Li JD; Basbaum C
    FEBS Lett; 1998 Dec; 441(1):88-92. PubMed ID: 9877171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
    Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
    J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation.
    Peng K; Liu L; Wei D; Lv Y; Wang G; Xiong W; Wang X; Altaf A; Wang L; He D; Wang H; Qu P
    Int J Mol Med; 2015 May; 35(5):1179-88. PubMed ID: 25761252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes.
    Siwik DA; Kuster GM; Brahmbhatt JV; Zaidi Z; Malik J; Ooi H; Ghorayeb G
    J Mol Cell Cardiol; 2008 Jan; 44(1):210-7. PubMed ID: 17869266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal expression of metalloproteinase-8 and -13 and their relationships with extracellular matrix metalloproteinase inducer in the development of ligature-induced periodontitis in rats.
    Yang D; Wang J; Ni J; Shang S; Liu L; Xiang J; Li C
    J Periodontal Res; 2013 Aug; 48(4):411-9. PubMed ID: 23083375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma.
    Ge H; Zhang JF; Guo BS; He Q; Wang BY; He B; Wang CQ
    Vascul Pharmacol; 2007 Feb; 46(2):114-21. PubMed ID: 17055343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(-/-) mice.
    Chen J; Cao J; Fang L; Liu B; Zhou Q; Sun Y; Wang Y; Li Y; Meng S
    J Transl Med; 2014 Nov; 12():326. PubMed ID: 25425200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms.
    Sluijter JP; Pulskens WP; Schoneveld AH; Velema E; Strijder CF; Moll F; de Vries JP; Verheijen J; Hanemaaijer R; de Kleijn DP; Pasterkamp G
    Stroke; 2006 Jan; 37(1):235-9. PubMed ID: 16339461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.